Welcome to the PREVAIL Trial
PREVenting
infection using
Antimicrobial Impregnated
Long lines
PREVAIL is a Phase 3 Randomised Unblinded Trial, aiming to recruit 858 babies over 2 years, from 18 Neonatal Units across England.
The trial will determine the effectiveness and cost-effectiveness of antimicrobial impregnated Premicath catheters (Premistars) compared with standard Premicath for reducing Blood Stream Infection (BSI) in neonates.
